PubRank
Search
About
A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
Clinical Trial ID NCT01006980
PubWeight™ 130.69
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01006980
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
Next 100